Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating activities:
Net loss	$ (105,063)	$ (247,740)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	14,978	10,201
Expensed in-process research and development		2,679
Premium amortization and discount accretion on investment securities	(556)	1,450
Stock-based compensation	131,858	84,789
Non-cash lease expense	7,204	7,451
Amortization of debt discount and issuance cost	658	642
Foreign exchange adjustment	377	265
Non-cash interest expense	(13)	68
Changes in operating assets and liabilities:
Accounts receivable	(57,647)	(15,680)
Inventory	(225)	(7,281)
Prepaid expenses and other assets	20,874	12,590
Accounts payable	16,668	(9,018)
Accrued compensation	19,701	9,936
Operating lease liabilities	(8,269)	(5,196)
Other accrued liabilities	(10,598)	(11,175)
Deferred revenue	1,044	6,368
Cash provided by (used in) operating activities	30,991	(159,651)
Investing activities:
Purchases of investments	(72,810)
Proceeds from maturity of investments	221,500	83,250
Purchases of property and equipment, net	(31,993)	(20,190)
Cash paid for acquisition of intangible assets	(10,495)
Cash provided by investing activities	106,202	63,060
Financing activities:
Proceeds from exercise of stock options	8,648	2,939
Proceeds from the issuance of common stock under the employee stock purchase plan	8,862	8,674
Cash provided by financing activities	17,510	11,613
Net change in cash, cash equivalents and restricted cash	154,703	(84,978)
Cash, cash equivalents and restricted cash, beginning of period	642,095	466,091
Cash, cash equivalents and restricted cash, end of period	796,798	381,113
Supplemental disclosure of cash flow information:
Cash paid for interest	5,592	5,596
Non-cash investing and financing activities:
Purchases of property and equipment in accounts payable and accruals	2,245	103
Acquisition of warrants	1,884
Amounts accrued for acquisition of intangible assets	1,400
Issuance of common stock for IPR&D acquisition		14,435
Issuance of common stock for bonuses	24,071	19,771
Stock-based compensation included in capitalized software development costs	$ 1,089	$ 376